A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis

Clinical trial NCT04612699 · COMPLETED

Trial details

NCT number: NCT04612699
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate-to-Severe Plaque Psoriasis

Start date: 2021-03-11
Primary completion: 2022-08-15
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.